27
Participants
Start Date
June 8, 2021
Primary Completion Date
April 30, 2026
Study Completion Date
June 30, 2026
Isatuximab
"Isatuximab in IV form (10mg/kg q weekly x 4 doses followed by 10mg/kg q 2 weeks) for a total of 6 month duration. Doses should be initiated at 175 mg/hour up to a maximum of 400 mg/hour.~Isatuximab (SAR) is monoclonal antibody (mAb)."
RECRUITING
Columbia University Irving Medical Center, New York
RECRUITING
Massachusetts General Hospital, Renal Associates Clinic, Boston
Genzyme, a Sanofi Company
INDUSTRY
Columbia University
OTHER